Egelston, Colt A.
Guo, Weihua
Yost, Susan E.
Ge, Xuan
Lee, Jin Sun
Frankel, Paul H.
Cui, Yujie
Ruel, Christopher
Schmolze, Daniel
Murga, Mireya
Tang, Aileen
Martinez, Norma
Karimi, Misagh
Somlo, George
Lee, Peter P.
Waisman, James R.
Yuan, Yuan http://orcid.org/0000-0001-7440-8939
Funding for this research was provided by:
Circle 1500
National Institutes of Health (RO1CA206911)
Cedars-Sinai Medical Center
Article History
Received: 18 August 2022
Accepted: 18 May 2023
First Online: 9 June 2023
Declarations
:
: Dr. Yuan has contracted research sponsored by Imugene, Minerva, Merck, Novartis, Genentech, and Pfizer, is a consultant for Pfizer, Immunomedics, and is on the Speakers Bureau for Genentech, AstraZeneca, Daiichi Sankyo, and Gilead. The other authors declare that they have no competing interests.
: The study was approved by City of Hope IRB registered under NCT02648477. Procedures were performed in accordance with the ethical standards of the City of Hope, the national research committee, and the 1964 Declaration of Helsinki and International Conference on Harmonization Guidelines for Good Clinical Practice and later amendments.
: Not applicable.